KMT2A / MLLT4 t(6;11) Fusion probe hybridized to patient material showing 47,XX,t(6;11)(q27;q23),+der(6)t(6;11) (q27;q23).
KMT2A / MLLT4 t(6;11) Fusion probe hybridized to patient material showing 47,XX,t(6;11)(q27;q23),+der(6)t(6;11) (q27;q23).
IVD KMT2A/MLLT4
One of the relatively frequently observed translocations in AML involves the genes KMT2A and MLLT4 (previously known as AF6) at 11q23 and 6q27. The KMT2A/MLLT4 translocation results in the generation of fusion protein that retains the KMT2A N-terminus, including both an A-T hook domain and a region similar to mammalian DNA methyltransferase. The breakpoint region of the MLLT4 gene is located within intron 1 and downstream of the initiation codon. The KMT2A/MLLT4 t(6;11) Fusion FISH probe is optimized to detect translocations involving the KMT2A (previously known as MLL) and MLLT4 gene regions at 11q23 and 6q27 in a dual-color, fusion assay on metaphase/interphase spreads, blood smears and bone marrow cells.
References: Mitterbauer-Hohdanner G et al, 2004, Eur J Clin Invest, 34; 12-24. Meyer C et al, 2009, Leukemia, 23; 1490-1499.
产品
产品
KBI-10309
KMT2A/MLLT4 t(6;11) Fusion
Product is out of stock
Due to manufacturing & supply chain issues, this product is currently unavailable. You may place your order and it will be fulfilled when the product is back in stock. For more help, please reach out to customer service at +1 844 534 2262 or nonurgentcs@leicabiosystems.com
Product is limited in stock
Product availability is limited, but products are in continuous production. Your order will be processed as normal and may take additional days to ship.